Singapore HSA-ACE Priority Track: Faster Market Access for Innovative Medical Devices

Singapore's Health Sciences Authority (HSA) has announced a new priority pathway for innovative medical devices, launching in November 2026. The 'HSA-Agency for Care Effectiveness (ACE) Priority Track' enables simultaneous regulatory review by the HSA and Health Technology Assessment (HTA) by ACE. This episode breaks down how this parallel evaluation process aims to cut the time to a first HTA decision from one year to just six months post-approval, and what it means for manufacturers seeking faster market access and reimbursement in Singapore. Key Questions: - What is the new HSA-ACE Priority Track for medical devices in Singapore? - When will this new accelerated pathway become available to manufacturers? - How does the simultaneous review by HSA and ACE speed up market access? - What is the expected reduction in the timeline for a Health Technology Assessment (HTA) decision? - Which types of innovative medical devices are eligible for this priority track? - What are the strategic implications for a company's evidence generation plan? - How should regulatory and market access teams prepare for this new process? - Why is early engagement with both HSA and ACE now more important than ever? Sources: - https://www.channelnewsasia.com/singapore/hsa-healthcare-innovation-clinical-research-hub-priority-track-3840131 - https://indiplomacy.com/singapore-hsa-announces-three-initiatives-to-accelerate-clinical-research-and-healthcare-innovation/ - https://www.instagram.com/p/C_SgN45yS-T/ - https://healthcareasiamagazine.com/healthcare/news/sg-slashes-clinical-trial-red-tape-speeds-health-tech-reviews How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies, streamlining global market access. We act as your local representative and manage device registrations in over 30 countries, including key Asia-Pacific markets like Singapore. Our experts develop efficient regulatory strategies and use advanced AI to compile and submit technical dossiers, minimizing delays. For support with Singapore's new priority track or your broader global expansion, contact us at info@pureglobal.com or visit https://pureglobal.com. Explore our free AI-powered regulatory tools and extensive device database at https://pureglobal.ai to accelerate your research and planning.